Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice

Neuropharmacology

Volumn 60, Issue 2-3, 2011, Pages 397-404

  Kawasaki, Toshiyuki ^a,b   Ago, Yukio ^a   Yano, Koji ^a   Araki, Ryota ^a   Washida, Yusuke ^a   Onoe, Hirotaka ^b   Chaki, Shigeyuki ^c   Nakazato, Atsuro ^c   Hashimoto, Hitoshi ^a,d   Baba, Akemichi ^a   Takuma, Kazuhiro ^a   Matsuda, Toshio ^a,d  

^a OSAKA UNIVERSITY   (Japan)

^b RIKEN   (Japan)

^c TAISHO PHARMACEUTICAL CO LTD   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Depression; LY341495; mGluR2 3; MGS0039; Social isolation

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 AMINO 3 (3,4 DICHLOROBENZYLOXY) 6 FLUOROBICYCLO[3.1.0]HEXANE 2,6 DICARBOXYLIC ACID; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; DEPRESSION; DRUG BINDING; DRUG PROTEIN BINDING; FORCED SWIMMING TEST; HIPPOCAMPUS; IMMOBILIZATION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE STUDY; SOCIAL ISOLATION;

AMINO ACIDS; ANIMALS; HIPPOCAMPUS; MALE; MICE; PREFRONTAL CORTEX; PROTEIN BINDING; RECEPTORS, METABOTROPIC GLUTAMATE; SOCIAL ISOLATION; XANTHENES;

EID: 78650815511     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2010.10.009     Document Type: Article

References (55)

1. 1A receptor-mediated dopamine release in vivo in the frontal cortex of mice J. Neurochem. 83 2002 353 359
2. Y. Ago, K. Takahashi, S. Nakamura, H. Hashimoto, A. Baba, and T. Matsuda Anxiety-like and exploratory behaviors of isolation-reared mice in the staircase test J. Pharmacol. Sci. 104 2007 153 158
3. Y. Ago, S. Arikawa, M. Yata, K. Yano, M. Abe, K. Takuma, and T. Matsuda Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression Neuropharmacology 55 2008 1355 1363
4. Y. Ayhan, A. Sawa, C.A. Ross, and M.V. Pletnikov Animal models of gene-environment interactions in schizophrenia Behav. Brain Res. 204 2009 274 281
5. J.C. Brenes, O. Rodríguez, and J. Fornazuera Differential effect of environment enrichment and social isolation on depressive-like behavior, spontaneous activity and serotonin and norepinephrine concentration in prefrontal cortex and ventral striatum Pharmacol. Biochem. Behav. 89 2008 85 93
6. J. Cartmell, J.A. Monn, and D.D. Schoepp Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268, and comparison with the atypical antipsychotic, clozapine Psychopharmacology (Berl.) 148 2000 423 429
7. J. Cartmell, K.W. Perry, C.R. Salhoff, J.A. Monn, and D.D. Schoepp The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat J. Neurochem. 75 2000 1147 1154
8. J. Cartmell, and D.D. Schoepp Regulation of neurotransmitter release by metabotropic glutamate receptors J. Neurochem. 75 2000 889 907
9. S. Chaki, R. Yoshikawa, S. Hirota, T. Shimazaki, M. Maeda, N. Kawashima, T. Yoshimizu, A. Yasuhara, K. Sakagami, S. Okuyama, S. Nakanishi, and A. Nakazato MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity Neuropharmacology 46 2004 457 467 (Pubitemid 38224431)
10. K.M. Day-Wilson, D.N. Jones, E. Southam, J. Cilia, and S. Totterdell Medial prefrontal cortex volume loss in rats with isolation rearing-induced deficits in prepulse inhibition of acoustic startle Neuroscience 141 2006 1113 1121
11. A. Del Arco, S. Zhu, A. Terasmaa, A.H. Mohammed, and K. Fuxe Hyperactivity to novelty induced by social isolation is not correlated with changes in D2 receptor function and binding in striatum Psychopharmacology (Berl.) 171 2004 148 155
12. C.H. Duman, L. Schlesinger, M. Kodama, D.S. Russell, and R.S. Duman A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment Biol. Psychiatr. 61 2007 661 670
13. M.J. Fell, K.A. Svensson, B.G. Johnson, and D.D. Schoepp Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1 R,4 S,5 S,6 S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039) J. Pharmacol. Exp. Ther. 326 2008 209 217
14. A.M. Feyissa, W.L. Woolverton, J.J. Miguel-Hidalgo, Z. Wang, P.B. Kyle, G. Hasler, C.A. Stockmeier, A.H. Iyo, and B. Karolewicz Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression Prog. Neuropsychopharmacol. Biol. Psychiatr. 34 2010 279 283
15. K.C. Fone, and M.V. Porkess Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders Neurosci. Biobehav. Rev. 32 2008 1087 1102
16. M.A. Geyer, K. Krebs-Thomson, D.L. Braff, and N.R. Swerdlow Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review Psychopharmacology (Berl.) 156 2001 117 154
17. J. González-Maeso, R.L. Ang, T. Yuen, P. Chan, N.V. Weisstaub, J.F. López-Giménez, M. Zhou, Y. Okawa, L.F. Callado, G. Milligan, J.A. Gingrich, M. Filizola, J.J. Meana, and S.C. Sealfon Identification of a serotonin/glutamate receptor complex implicated in psychosis Nature 452 2008 93 97
18. R.G. Greenslade, and S.N. Mitchell Selective action of (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell Neuropharmacology 47 2004 1 8
19. F.S. Hall, L.S. Wilkinson, T. Humby, W. Inglis, D.A. Kendall, C.A. Marsden, and T.W. Robbins Isolation rearing in rats: pre- and postsynaptic changes in striatal dopaminergic systems Pharmacol. Biochem. Behav. 59 1998 859 872
20. M.K. Harte, S.B. Powell, L.M. Reynolds, N.R. Swerdlow, M.A. Geyer, and G.P. Reynolds Reduced N-acetylaspartate in the temporal cortex of rats reared in isolation Biol. Psychiatr. 56 2004 296 299
21. C.A. Heidbreder, I.C. Weiss, A.M. Domeney, C. Pryce, J. Homberg, G. Hedou, J. Feldon, M.C. Moran, and P. Nelson Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome Neuroscience 100 2000 749 768
22. A. Hetzenauer, C. Corti, S. Herdy, M. Corsi, F. Ferraguti, and N. Singewald Individual contribution of metabotropic glutamate receptor (mGlu) 2 and 3 to c-Fos expression pattern evoked by mGlu2/3 antagonism Psychopharmacology (Berl.) 201 2008 1 13
23. L.A. Hilakivi, M. Ota, and R.G. Lister Effect of isolation on brain monoamines and the behavior of mice in tests of exploration, locomotion, anxiety and behavioral 'despair' Pharmacol. Biochem. Behav. 33 1989 371 374
24. G. Imre The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268 CNS Drug Rev. 13 2007 444 464
25. J. Karasawa, T. Shimazaki, N. Kawashima, and S. Chaki AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist Brain Res. 1042 2005 92 98
26. K. Koda, Y. Ago, T. Kawasaki, H. Hashimoto, A. Baba, and T. Matsuda Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice Psychopharmacology (Berl.) 196 2008 293 301
27. L. Lu, G. Bao, H. Chen, P. Xia, X. Fan, J. Zhang, G. Pei, and L. Ma Modification of hippocampal neurogenesis and neuroplasticity by social environments Exp. Neurol. 183 2003 600 609
28. F. Matrisciano, M. Storto, R.T. Ngomba, I. Cappuccio, A. Caricasole, S. Scaccianoce, B. Riozzi, D. Melchiorri, and F. Nicoletti Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus Neuropharmacology 42 2002 1008 1015
29. F. Matrisciano, A. Caruso, R. Orlando, M. Marchiafava, V. Bruno, G. Battaglia, S.H. Gruber, D. Melchiorri, R. Tatarelli, P. Girardi, A.A. Math, and F. Nicoletti Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats Neuropharmacology 55 2008 525 531
30. R.I. Melendez, M.L. Gregory, M.T. Bardo, and P.W. Kalivas Impoverished rearing environment alters metabotropic glutamate receptor expression and function in the prefrontal cortex Neuropsychopharmacology 29 2004 1980 1987
31. B. Moghaddam, and B.W. Adams Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats Science 281 1998 1349 1352
32. S. Muchimapura, R. Mason, and C.A. Marsden Effect of isolation rearing on pre- and post-synaptic serotonergic function in the rat dorsal hippocampus Synapse 47 2003 209 217
33. S. Nakanishi Molecular diversity of glutamate receptors and implications for brain function Science 258 1992 597 603
34. 3-receptor knockout mice J. Pharmacol. Sci. 111 2009 167 174
35. K. Ossowska, M. Pietraszek, J. Wardas, G. Nowak, W. Zajaczkowski, S. Wolfarth, and A. Pilc The role of glutamate receptors in antipsychotic drug action Amino Acids 19 2000 87 94
36. A. Pałucha, P. Brański, K. Kĺak, and M. Sowa Chronic imipramine treatment reduces inhibitory properties of group II mGlu receptors without affecting their density or affinity Pharmacol. Rep. 59 2007 525 530
37. S.T. Patil, L. Zhang, F. Martenyi, S.L. Lowe, K.A. Jackson, B.V. Andreev, A.S. Avedisova, L.M. Bardenstein, I.Y. Gurovich, M.A. Morozova, S.N. Mosolov, N.G. Neznanov, A.M. Reznik, A.B. Smulevich, V.A. Tochilov, B.G. Johnson, J.A. Monn, and D.D. Schoepp Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial Nat. Med. 13 2007 1102 1107
38. A. Pilc, S. Chaki, G. Nowak, and J.M. Witkin Mood disorders: regulation by metabotropic glutamate receptors Biochem. Pharmacol. 75 2008 997 1006
39. J.P. Pin, and R. Duvoisin The metabotropic glutamate receptors: structure and functions Neuropharmacology 34 1995 1 26
40. 2A receptors in isolation-reared rats: an in vitro autoradiography study Neuroscience 123 2004 725 732
41. L.M. Rorick-Kehn, B.G. Johnson, K.M. Knitowski, C.R. Salhoff, J.M. Witkin, K.W. Perry, K.I. Griffey, J.P. Tizzano, J.A. Monn, D.L. McKinzie, and D.D. Schoepp In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders Psychopharmacology (Berl.) 193 2007 121 136
42. 1A receptor activation in isolated mice Eur. J. Pharmacol. 432 2001 163 166
43. G. Sanacora, C.A. Zarate, J.H. Krystal, and H.K. Manji Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders Nat. Rev. Drug Discov. 7 2008 426 437
44. M.I. Schubert, M.V. Porkess, N. Dashdorj, K.C. Fone, and D.P. Auer Effects of social isolation rearing on the limbic brain: a combined behavioral and magnetic resonance imaging volumetry study in rats Neuroscience 159 2009 21 30
45. A.B. Silva-Gómez, D. Rojas, I. Juárez, and G. Flores Decreased dendritic spine density on prefrontal cortical and hippocampal pyramidal neurons in postweaning social isolation rats Brain Res. 983 2003 128 136
46. K. Takamori, S. Hirota, S. Chaki, and M. Tanaka Antipsychotic action of selective group II metabotropic glutamate receptor agonist MGS0008 and MGS0028 on conditioned avoidance responses in the rat Life Sci. 73 2003 1721 1728
47. 1 receptor binding in rats Neuroscience 165 2010 492 499
48. J.J. Turnock-Jones, C.A. Jennings, M.J. Robbins, J.E. Cluderay, J. Cilia, J.L. Reid, A. Taylor, D.N. Jones, P.C. Emson, and E. Southam Increased expression of the NR2A NMDA receptor subunit in the prefrontal cortex of rats reared in isolation Synapse 63 2009 836 846
49. I.C. Weiss, and J. Feldon Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review Psychopharmacology (Berl.) 156 2001 305 326
50. J.M. Wierońska, B. Legutko, D. Dudys, and A. Pilc Olfactory bulbectomy and amitriptyline treatment influences mGlu receptors expression in the mouse brain hippocampus Pharmacol. Rep. 60 2008 844 855
51. J.M. Witkin, G.J. Marek, B.G. Johnson, and D.D. Schoepp Metabotropic glutamate receptors in the control of mood disorders CNS Neurol. Disord. Drug Targets 6 2007 87 100
52. 3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain J. Pharmacol. Exp. Ther. 298 2001 453 460
53. A. Yasuhara, M. Nakamura, K. Sakagami, T. Shimazaki, R. Yoshikawa, S. Chaki, H. Ohta, and A. Nakazato Prodrugs of 3-(3,4-dichlorobenzyloxy)-2-amino-6- fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (MGS0039): a potent and orally active group II mGluR antagonist with antidepressant-like potential Bioorg. Med. Chem. 14 2006 4193 4207
54. T. Yoshimizu, T. Shimazaki, A. Ito, and S. Chaki An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats Psychopharmacology 186 2006 587 593
55. X. Zhao, L. Sun, H. Jia, Q. Meng, S. Wu, N. Li, and S. He Isolation rearing induces social and emotional function abnormalities and alters glutamate and neurodevelopment-related gene expression in rats Prog. Neuropsychopharmacol. Biol. Psychiatr. 33 2009 1173 1177